VAERS Explorer
Back to explore

Report #2832613

Received Mar 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (NO BRAND NAME)UNKNOWN MANUFACTURERUNKUNK—

Symptoms (1)

Autism spectrum disorder

Symptom narrative

now he has autism; This serious case was reported by a consumer via call center representative and described the occurrence of autism in a male patient who received DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis. On an unknown date, the patient received Tdap Vaccine. On an unknown date, an unknown time after receiving Tdap Vaccine, the patient experienced autism (Verbatim: now he has autism) (serious criteria GSK medically significant). The outcome of the autism was not resolved. It was unknown if the reporter considered the autism to be related to Tdap Vaccine. The company considered the autism to be unrelated to Tdap Vaccine. Additional Information: GSK Receipt Date: 14-MAR-2025 The patient's mother reported this case. The patient (son) received Tdap vaccine many years ago and now he had autism.; Sender's Comments: Autism spectrum disorder is an unlisted event which is considered unrelated to GSK Tdap Vaccine.